These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25546756)

  • 21. High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy.
    Nobile-Orazio E; Cocito D; Briani C; Plasmati R; Schenone A; Gallia F; Marjanovic I; Suffredini AL
    Neurol Sci; 2017 May; 38(5):899-902. PubMed ID: 28144763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal motor neuropathy presenting as a post-infectious complication of dengue: a CASE report.
    Higgoda R; Perera D; Thirumavalavan K
    BMC Infect Dis; 2018 Aug; 18(1):415. PubMed ID: 30134860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifocal motor neuropathy.
    Nguyen TP; Chaudhry V
    Neurol India; 2011; 59(5):700-6. PubMed ID: 22019654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy.
    Terenghi F; Allaria S; Nobile-Orazio E
    J Peripher Nerv Syst; 2006 Mar; 11(1):67-71. PubMed ID: 16519784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical rules for electrodiagnosis in suspected multifocal motor neuropathy.
    Bromberg MB; Franssen H
    J Clin Neuromuscul Dis; 2015 Mar; 16(3):141-52. PubMed ID: 25695919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic relapsing axonal neuropathy responsive to intravenous immunoglobulin.
    Katirji B
    Neurology; 1997 Jun; 48(6):1690-4. PubMed ID: 9191788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual recovery from acute panautonomic neuropathy after immunoglobulin therapy.
    Smit AA; Vermeulen M; Koelman JH; Wieling W
    Mayo Clin Proc; 1997 Apr; 72(4):333-5. PubMed ID: 9121180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-exposure-efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy.
    Li Z; Roepcke S; Franke R; Yel L
    Ann Clin Transl Neurol; 2024 Aug; 11(8):1977-1987. PubMed ID: 38978354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood-onset multifocal motor neuropathy with conduction blocks.
    Moroni I; Bugiani M; Ciano C; Bono R; Pareyson D
    Neurology; 2006 Mar; 66(6):922-4. PubMed ID: 16567714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do A-waves help predict intravenous immunoglobulin response in multifocal motor neuropathy without block?
    Lange DJ; Nijjar R; Voustianiouk A; Seidel G; Panchal J; Wang AK
    Muscle Nerve; 2011 Apr; 43(4):537-42. PubMed ID: 21305570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of immunoglobulin (Ig) in peripheral neuropathies. Impact of Ig on remission rates: comparison of intravenous immunoglobulin and subcutaneous immunoglobulin.
    Yoon MS
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):25-6. PubMed ID: 25546750
    [No Abstract]   [Full Text] [Related]  

  • 33. Multifocal motor neuropathy.
    Muley SA; Parry GJ
    J Clin Neurosci; 2012 Sep; 19(9):1201-9. PubMed ID: 22743043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
    Lunn MP; Ellis L; Hadden RD; Rajabally YA; Winer JB; Reilly MM
    J Peripher Nerv Syst; 2016 Mar; 21(1):33-7. PubMed ID: 26757367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal motor neuropathy.
    Van Asseldonk JT; Franssen H; Van den Berg-Vos RM; Wokke JH; Van den Berg LH
    Lancet Neurol; 2005 May; 4(5):309-19. PubMed ID: 15847844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.
    Karam C
    Neurology; 2011 Mar; 76(13):1194; author reply 1194-5. PubMed ID: 21444910
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmune-mediated polyneuropathy triggered by borrelial infection?
    Rupprecht TA; Elstner M; Weil S; Pfister HW
    Muscle Nerve; 2008 Jun; 37(6):781-5. PubMed ID: 18288714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
    Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
    J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.
    Harbo T; Andersen H; Hess A; Hansen K; Sindrup SH; Jakobsen J
    Eur J Neurol; 2009 May; 16(5):631-8. PubMed ID: 19236457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifocal motor neuropathy improved by IVIg.
    Turnbull J
    Neurology; 2001 Jun; 56(11):1608. PubMed ID: 11402138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.